Biennial breast cancer screening that combines digital mammography and tomosynthesis not only increases breast cancer detection in women with dense breasts compared with mammography alone, it does so while remaining cost-effective, according to a study published online Oct. 28 in Radiology.

Toxins produced by highly specialized stem cells work to treat brain cancer. Researchers from Harvard Medical School are the engineers behind these killer stem cells.

Toshiba is bringing what is being called the industry’s largest-bore PET/CT to the upcoming Radiological Society of North America (RSNA) annual meeting next month in Chicago from Nov. 30-Dec. 5, according to an Oct. 27 announcement.

Eli Lilly and Company, makers of amyloid PET agent Amyvid, announced yesterday evening that the judge in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, has ruled to reduce punitive damages for defendants Takeda and Lilly from $6 billion and $3 billion, respectively, down to $27.6 million and $9.2 million.

A relatively new MR technique that vastly improves imaging resolution is able to find the minute lung pathology associated with smoking habits—even before respiratory symptoms become a drag, according to a study published ahead of print Oct. 13 in Radiology.

Rick Gonzalez, former vice president of global operations for Spectrum Pharmaceuticals, is the new chief executive officer for Navidea Biopharmaceuticals, producers of Lymphoseek, the company announced recently.

Sofie Biosciences, producers of PET imaging systems and agents, has been awarded a two-year $1.5 million phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute to further develop oncologic PET agents, the company recently announced.

The National Institutes of Health (NIH) will be bankrolling a Small Business Innovation Research (SBIR) grant for Austin-based NanoHybrids to develop contrast agents for the detection of atherosclerotic plaques, the company announced today.